Emerging therapeutic targets and strategies in Crohn's disease

Expert Review of Gastroenterology & Hepatology
Federica FurfaroSilvio Danese

Abstract

Crohn's disease (CD) is an immune-mediated inflammatory bowel disease, in which inflammation is driven by a complex interaction between the microbiota, immune cells, genes and mediators. New mechanisms of action and several cytokines have been identified as factors involved in the inflammatory process in CD, and many new molecules have been developed to treat this complex disease. New agents have been developed that target leukocyte trafficking, block or adhesion molecules for example, as well as the development of antibodies against classic inflammatory cytokines or therapies directed against IL-12/23 and Janus kinases. The development of selective mechanisms of action and targeting of different cytokines or inflammatory mediators for each patient presents the biggest challenge for the future in CD therapy. Such agents are currently at different phases of development. We aim to review the current literature data on a targeted approach in CD, which could be promising alternative approach for CD patients in the near future.

References

Apr 21, 2001·Gastroenterology·S SchreiberUNKNOWN German ICAM-1 Study Group
Jan 3, 2003·The New England Journal of Medicine·Subrata GhoshUNKNOWN Natalizumab Pan-European Study Group
Jun 28, 2003·Trends in Molecular Medicine·Klaus Ley
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
Feb 14, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bruce YacyshynEmil Chuang
May 9, 2007·Gastroenterology·Stephan R TarganUNKNOWN International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group
Aug 19, 2008·Gastroenterology·William J SandbornUNKNOWN Ustekinumab Crohn's Disease Study Group
Aug 14, 2009·Current Opinion in Pharmacology·Maximilian J Waldner, Markus F Neurath
Nov 20, 2009·The New England Journal of Medicine·Clara Abraham, Judy H Cho
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
Dec 30, 2011·Inflammopharmacology·Saskia Thomas, Daniel C Baumgart
Mar 16, 2012·The New England Journal of Medicine·Giancarlo ComiUNKNOWN ALLEGRO Study Group
May 18, 2012·The New England Journal of Medicine·Gary BloomgrenCarmen Bozic
Aug 17, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN Study A3921063 Investigators
Oct 19, 2012·The New England Journal of Medicine·William J SandbornUNKNOWN CERTIFI Study Group
Dec 4, 2012·Journal of Crohn's & Colitis·Martin BortlikMilan Lukas
Mar 26, 2013·PloS One·Satish KeshavUNKNOWN Prospective Randomized Oral-Therapy Evaluation in Crohn’s Disease Trial-1 PROTECT-1 Study Group
Apr 6, 2013·Expert Review of Clinical Immunology·Monica Cesarini, Gionata Fiorino
Jun 25, 2013·Autoimmunity Reviews·Shomron Ben-HorinYehuda Chowers
Aug 2, 2013·Immunotherapy·Reena Khanna, Brian G Feagan
Aug 24, 2013·The New England Journal of Medicine·William J SandbornUNKNOWN GEMINI 2 Study Group
Oct 10, 2013·Current Drug Targets·Mariangela AlloccaSilvio Danese
Nov 20, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Monica CesariniGionata Fiorino
Jan 21, 2014·Annales pharmaceutiques françaises·P Bourlioux
Feb 1, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·William J SandbornUNKNOWN Study A3921043 Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Related Papers

Current Drug Targets
Elena RicartJulián Panés
World Journal of Gastroenterology : WJG
Jannie PedersenOle Haagen Nielsen
Mediators of Inflammation
Bruno Rafael Ramos de MattosPatricia Ucelli Simioni
© 2022 Meta ULC. All rights reserved